A SynB1-conjugated antibody cocktail crosses the blood–brain barrier to produce a therapeutic effect on rabies
https://www.profitableratecpm.com/f4ffsdxe?key=39b1ebce72f3758345b2155c98e6709c
Proceedings of the National Academy of Sciences, Volume 122, Number 52, December 2025.
ImportanceThe treatment of rabies is limited by the poor ability to penetrate the blood-brain barrier (BBB) and the narrow epitope coverage of existing antibodies. We overcame this fundamental limitation by conjugating a cocktail of three antibodies…

:max_bytes(150000):strip_icc()/GettyImages-1198660415-0aef78799c924e759ef3cb976e8257a5.jpg?w=390&resize=390,220&ssl=1)

